Articles

Non-marketers need strategic marketing training: the case for change

22nd December 2014

Non-marketers need strategic marketing training:  the case for changeMichael Craig

Strategic marketing competencies should be written into medical, clinical, regulatory and market access job descriptions, as every department has a part to play, says Michael Craig.Pharmaceutical brand success is now... Read more

AstraZeneca: reinvigorating a UK pharma giant

19th December 2014

AstraZeneca: reinvigorating a UK pharma giantAndrew McConaghie

Lisa Anson, President of AstraZeneca UK & Ireland, talks to pharmaphorum about living through Pfizer's takeover bid and the company's expanding presence in diabetes and respiratory disease.As 2014 draws to... Read more

10 social media events that changed healthcare in 2014

18th December 2014

10 social media events that changed healthcare in 2014Daniel Ghinn

This month, Daniel Ghinn reviews some of the key online happenings that have had an impact on healthcare over the year.The year 2014 has been incredible for social media in... Read more

Tunnah’s musings: Reviewing the health of 2014 on Google

17th December 2014

Tunnah’s musings: Reviewing the health of 2014 on GooglePaul Tunnah

As 2014 draws to a close Paul Tunnah takes a different tack on his review of the year for the pharmaceutical industry, using Google to search for his inspiration on... Read more

News

FDA clears AbbVie's hepatitis C regimen Viekira Pak

22nd December 2014

FDA clears AbbVie's hepatitis C regimen Viekira PakStaff reporter

AbbVie is celebrating after the US FDA approved its all-oral hepatitis C regimen Viekira Pak, which has been tipped by analysts to achieve peak sales of around $3 billion.The regimen... Read more

Lilly’s Cyramza approved in EU for stomach cancer

22nd December 2014

Lilly’s Cyramza approved in EU for stomach cancerLinda Banks

The European Commission has granted marketing authorisation (MA) for Eli Lilly's ramucirumab (Cyramza) in stomach cancer, making it the first therapy approved for second-line advanced stomach and gastro-oesophageal junction (GOJ)... Read more

Lilly and Adocia partner on ultra-rapid insulin for diabetes

19th December 2014

Lilly and Adocia partner on ultra-rapid insulin for diabetesLinda Banks

Eli Lilly and French biotech Adocia are to develop an ultra-rapid insulin, BioChaperone Lispro, for type 1 and type 2 diabetes. BioChaperone Lispro is based on Adocia's technology and is... Read more

Pfizer takes muscular dystrophy drug into phase II

19th December 2014

Pfizer takes muscular dystrophy drug into phase IIStaff reporter

Pfizer has started phase II trials of a candidate drug to treat Duchenne muscular dystrophy (DMD) as it plays catch-up with rivals PTC Therapeutics, Prosensa and Sarepta.The pharma giant has... Read more

Audio & Video

On demand webinar: The Price is Right? -…

Slide-300x200b

 

With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the... View more

Now on demand - real world insight into …

The Diabetes Debate

 

Now available on demand (free to access) - originally broadcast on October 29th 2014.


Non-adherence to self-management regimens in diabetes is globally... View more

On-demand webinar: Is pharma brand marke…

Kantar Health webinar


While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to... View more

View the conversation - Tweetchat: Manag…

Atlantis Healthcare diabetes Tweetchat


Working in partnership, Atlantis Healthcare and pharmaphorum conducted a Tweetchat focussed on the real world challenges patients face in managing... View more

White Papers

How do doctors want to engage with pharm…

How do doctors want to engage with pharma on new products?Dr Tim Ringrose

With more than 80 per cent of European doctors saying they want to stay abreast of new developments about pharmaceutical products, it is important to understand how they wish to... View info

Modelling patient behaviour to improve s…

Modelling patient behaviour to improve self-management in diabetesDr Sinéad NíMhurchadha & Jeremy Sayers

An understanding of health psychology is essential to helping patients adhere to their medication and lifestyle regimens. This report hones in on how the COM-B model of behaviour provides a... View info

"The future ain’t what it used to b…

"The future ain’t what it used to be"Paul Stuart-Kregor

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there... View info

Healthcare Innovation: the big ideas sha…

Healthcare Innovation: the big ideas shaping the future of pharmaDavid Rowley

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.

Long production cycles, concentration on specialist drugs with high... View info

Further News & Articles

Australia finally gives cystic fibrosis patients access to Kalydeco

After months of wrangling, Australia has listed Vertex' cystic fibrosis (CF) therapy Kalydeco in the Pharmaceuti... Read more

News

2015 Editorial Calendar and Submission Guidelines

Pharmaphorum Submission Guidelines

Want to write for pharmaphorum? If so please ... Read more

About pharmaphorum

Google Ventures increases healthcare investment

Google's venture capital division has embarked on a push into healthcare as it follows the lead of its parent co... Read more

News

Early Access: the ground rules for communicating with physicians and patients

How should medical departments, advocacy liaison leaders and communication teams in pharma companies deal with deman... Read more

Articles

NICE recommends Pfizer's kidney cancer treatment Inlyta

Pfizer is set to gain a NICE recommendation for its renal cell carcinoma treatment Inlyta, two years after it... Read more

News

Experimental Ebola blood therapy trial gets under way

Blood taken from survivors of Ebola could help protect others who contract the deadly disease, as part of a new ... Read more

News